Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
- PMID: 40555795
- DOI: 10.1038/s41574-025-01134-8
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Abstract
This Pituitary Society Consensus article presents an evidence-based consensus on the management of pituitary incidentaloma, defined as an unexpected sellar or parasellar finding incidentally discovered on an imaging study that was not performed for a clinically suspected pituitary lesion. Recommendations are offered for when endocrinology, neurosurgery and ophthalmology consultation, dedicated pituitary imaging, pituitary hormone testing and visual assessment are warranted for macroadenomas, microadenomas, cystic lesions and empty sella, as well as when surgical resection is indicated for incidental pituitary adenomas and cystic sellar lesions. Special considerations in patients with multiple endocrine neoplasia type 1, children and adolescents, older people, and pregnant women are addressed. The Consensus workshop concluded that diagnostic and management approaches should be individualized to the specific clinical context of an incidentally discovered pituitary lesion. Consultation with a multidisciplinary pituitary tumour centre of excellence should be considered in the presence of new or deteriorating lesion-specific signs or symptoms, particularly when surgical or other adjuvant interventions are being considered and when there is uncertainty about the most appropriate subsequent management.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Similar articles
-
NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").NIH Consens State Sci Statements. 2002 Feb 4-6;19(2):1-25. NIH Consens State Sci Statements. 2002. PMID: 14768652
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Baseline anatomical assessment of the uterus and ovaries in infertile women: a systematic review of the evidence on which assessment methods are the safest and most effective in terms of improving fertility outcomes.Hum Reprod Update. 2017 Sep 1;23(5):533-547. doi: 10.1093/humupd/dmx019. Hum Reprod Update. 2017. PMID: 28903473
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Budan, R. M. & Georgescu, C. E. Multiple pituitary adenomas: a systematic review. Front. Endocrinol. 7, 1 (2016). - DOI
Publication types
LinkOut - more resources
Full Text Sources